Immunovant, Inc. Share Price
NASDAQ: IMVT$0.00
+0.00 (0.00%) Immunovant, Inc. Stock Performance
Open N/A | Prev. Close N/A | Circuit Range N/A |
Day Range N/A | Year Range N/A | Volume N/A |
Average Traded N/A |
Immunovant, Inc. Share Price Chart
$0.00$0.00
L
H
Immunovant, Inc. Stock Fundamentals & Key Indicators
Market Cap N/A | PE Ratio (TTM) N/A | Dividend Yield N/A |
EPS (TTM) $-2.73 | Revenue (TTM) N/A | Return On Equity (TTM) -58.50% |
Profit Margin N/A | Debt to Equity 0.10 | Quarterly Earnings Growth YoY 0.44% |
Immunovant, Inc. Quarterly Profit & Loss
All figures in USD
Immunovant, Inc. Annual Profit & Loss
All figures in USD
About Immunovant, Inc.
Immunovant, Inc., a clinical-stage immunology company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops IMVT-1402 for graves' disease, rheumatoid arthritis, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, cutaneous lupus erythematosus disease, and sjögren's disease; and batoclimab for graves' disease and thyroid eye disease. The company has a license agreement with HanAll Biopharma Co., Ltd. for the rights of intellectual property relating to IMVT-1402 and batoclimab. Immunovant, Inc. was founded in 2018 and is based in New York, New York. Immunovant, Inc. is a subsidiary of Roivant Sciences Ltd.
Immunovant, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|
IMVT Share Price FAQs
What is Immunovant, Inc. share price today?
Immunovant, Inc. share price today is $0.00 as on August 9, 2026 at 12:12 pm IST.
What is the 52 week high and 52 week low of Immunovant, Inc. stock?
52 week high/low data for Immunovant, Inc. is currently unavailable.
What is IMVT's net income for the last quarter?
IMVT's net income for the last quarter is -0.11B USD.
Can I buy IMVT shares in India?
Yes. You can buy IMVT in India by opening an international trading account.